Galmed Pharmaceuticals Sets Annual Shareholder Meeting Date
Ticker: GLMD · Form: 6-K · Filed: Sep 19, 2025 · CIK: 1595353
| Field | Detail |
|---|---|
| Company | Galmed Pharmaceuticals LTD. (GLMD) |
| Form Type | 6-K |
| Filed Date | Sep 19, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, filing-update
Related Tickers: GLMD
TL;DR
Galmed (GLMD) holding shareholder meeting Oct 28th. All docs attached.
AI Summary
Galmed Pharmaceuticals Ltd. announced it will hold its Annual General Meeting of Shareholders on October 28, 2025, at 4:00 p.m. Israel time. The meeting will take place at the offices of Meitar Law Offices in Ramat Gan, Israel. Documents including the Notice of the Annual General Meeting, Proxy Statement, and Proxy Card are attached to this filing.
Why It Matters
This filing informs shareholders about the upcoming annual meeting where key corporate decisions and elections are typically made, allowing them to participate in the governance of the company.
Risk Assessment
Risk Level: low — This is a routine administrative filing announcing a shareholder meeting, with no new financial or operational information that would typically increase risk.
Key Players & Entities
- Galmed Pharmaceuticals Ltd. (company) — Registrant
- October 28, 2025 (date) — Annual General Meeting date
- Meitar Law Offices (company) — Legal counsel and meeting location
- Ramat Gan, Israel (location) — Meeting location
FAQ
When and where will Galmed Pharmaceuticals Ltd. hold its Annual General Meeting of Shareholders?
The Annual General Meeting of Shareholders will be held on October 28, 2025, at 4:00 p.m. (Israel time) at the offices of Meitar Law Offices in Ramat Gan, Israel.
What documents are attached to this Form 6-K filing?
A copy of the Notice of the Annual General Meeting of Shareholders, the Proxy Statement, and the Proxy Card are attached as Exhibit 99.1.
What is the exact address for the meeting?
The meeting will be held at 16 Abba Hillel Silver Rd., Ramat Gan, 5250608, Israel.
Does Galmed Pharmaceuticals Ltd. file annual reports under Form 20-F or Form 40-F?
Galmed Pharmaceuticals Ltd. indicates it files annual reports under Form 20-F.
What is the Commission File Number for Galmed Pharmaceuticals Ltd.?
The Commission File Number for Galmed Pharmaceuticals Ltd. is 001-36345.
Filing Stats: 280 words · 1 min read · ~1 pages · Grade level 10 · Accepted 2025-09-19 16:05:22
Filing Documents
- form6-k.htm (6-K) — 21KB
- ex99-1.htm (EX-99.1) — 111KB
- ex99-2.htm (EX-99.2) — 31KB
- ex99-2_001.jpg (GRAPHIC) — 1KB
- 0001493152-25-014239.txt ( ) — 165KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Galmed Pharmaceuticals Ltd. Date: September 19, 2025 By: /s/ Allen Baharaff Allen Baharaff President and Chief Executive Officer -3-